209 related articles for article (PubMed ID: 2313127)
1. Natural history of pertussis antibody in the infant and effect on vaccine response.
Van Savage J; Decker MD; Edwards KM; Sell SH; Karzon DT
J Infect Dis; 1990 Mar; 161(3):487-92. PubMed ID: 2313127
[TBL] [Abstract][Full Text] [Related]
2. Antibody responses after vaccination and disease against leukocytosis promoting factor, filamentous hemagglutinin, lipopolysaccharide and a protein binding to complement-fixing antibodies induced during whooping cough.
Winsnes R; Lønnes T; Møgster B; Berdal BP
Dev Biol Stand; 1985; 61():353-65. PubMed ID: 2872124
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of pertussis antibodies in maternal delivery, cord, and infant serum.
Healy CM; Munoz FM; Rench MA; Halasa NB; Edwards KM; Baker CJ
J Infect Dis; 2004 Jul; 190(2):335-40. PubMed ID: 15216470
[TBL] [Abstract][Full Text] [Related]
4. Immunogenicity of a three-component acellular pertussis vaccine administered at birth.
Belloni C; De Silvestri A; Tinelli C; Avanzini MA; Marconi M; Strano F; Rondini G; Chirico G
Pediatrics; 2003 May; 111(5 Pt 1):1042-5. PubMed ID: 12728086
[TBL] [Abstract][Full Text] [Related]
5. Optimization of immunization schedule to standardize antibody response in mice to pertussis vaccines.
Tiru M; Jäätmaa E; Gillenius P; Askelöf P
Dev Biol Stand; 1985; 61():469-75. PubMed ID: 2872128
[TBL] [Abstract][Full Text] [Related]
6. Immunogenicity of an acellular pertussis vaccine composed of genetically inactivated pertussis toxin combined with filamentous hemagglutinin and pertactin in infants and children.
Podda A; Carapella De Luca E; Titone L; Casadei AM; Cascio A; Bartalini M; Volpini G; Peppoloni S; Marsili I; Nencioni L
J Pediatr; 1993 Jul; 123(1):81-4. PubMed ID: 8320630
[TBL] [Abstract][Full Text] [Related]
7. Anti-pertussis toxin IgG and anti-filamentous hemagglutinin IgG production in children immunized with pertussis acellular vaccine and comparison of these titers with the sera of pertussis convalescent children.
Sato Y; Sato H
Dev Biol Stand; 1985; 61():367-72. PubMed ID: 3835079
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of a new highly purified pertussis vaccine in infants and children.
Edwards KM; Bradley RB; Decker MD; Palmer PS; Van Savage J; Taylor JC; Dupont WD; Hager CC; Wright PF
J Infect Dis; 1989 Nov; 160(5):832-7. PubMed ID: 2809258
[TBL] [Abstract][Full Text] [Related]
9. Dynamics of transplacental transmission of pertussis antibodies in premature and full-term infants.
Nomura M; Kuno-Sakai H; Kimura M; Ichikawa I
Tokai J Exp Clin Med; 2003 Apr; 28(1):21-6. PubMed ID: 12880300
[No Abstract] [Full Text] [Related]
10. Acellular pertussis vaccines in infants: evaluation of single component and two-component products.
Anderson EL; Mink CM; Berlin BS; Shih CN; Tung FF; Belshe RB
Vaccine; 1994 Jan; 12(1):28-31. PubMed ID: 8303937
[TBL] [Abstract][Full Text] [Related]
11. Serological response to filamentous hemagglutinin and lymphocytosis-promoting toxin of Bordetella pertussis.
Burstyn DG; Baraff LJ; Peppler MS; Leake RD; St Geme J; Manclark CR
Infect Immun; 1983 Sep; 41(3):1150-6. PubMed ID: 6309662
[TBL] [Abstract][Full Text] [Related]
12. Acellular pertussis vaccine in adults: adverse reactions and immune response.
Granström M; Thorén M; Blennow M; Tiru M; Sato Y
Eur J Clin Microbiol; 1987 Feb; 6(1):18-21. PubMed ID: 2883004
[TBL] [Abstract][Full Text] [Related]
13. Antibody responses to Bordetella pertussis and other childhood vaccines in infants born to mothers who received pertussis vaccine in pregnancy - a prospective, observational cohort study from the United Kingdom.
Rice TF; Diavatopoulos DA; Smits GP; van Gageldonk PGM; Berbers GAM; van der Klis FR; Vamvakas G; Donaldson B; Bouqueau M; Holder B; Kampmann B
Clin Exp Immunol; 2019 Jul; 197(1):1-10. PubMed ID: 30758857
[TBL] [Abstract][Full Text] [Related]
14. Acquisition of specific antibodies and their influence on cell-mediated immune response in neonatal cord blood after maternal pertussis vaccination during pregnancy.
Lima L; Molina MDGF; Pereira BS; Nadaf MLA; Nadaf MIV; Takano OA; Carneiro-Sampaio M; Palmeira P
Vaccine; 2019 May; 37(19):2569-2579. PubMed ID: 30955978
[TBL] [Abstract][Full Text] [Related]
15. Pertussis seroepidemiology in women and their infants in Sarlahi District, Nepal.
Hughes MM; Englund JA; Edwards K; Yoder S; Tielsch JM; Steinhoff M; Khatry SK; LeClerq SC; Katz J
Vaccine; 2017 Dec; 35(48 Pt B):6766-6773. PubMed ID: 29037576
[TBL] [Abstract][Full Text] [Related]
16. Serum IgG, IgA, and IgM responses to pertussis toxin, filamentous hemagglutinin, and agglutinogens 2 and 3 after infection with Bordetella pertussis and immunization with whole-cell pertussis vaccine.
Thomas MG; Ashworth LA; Miller E; Lambert HP
J Infect Dis; 1989 Nov; 160(5):838-45. PubMed ID: 2572651
[TBL] [Abstract][Full Text] [Related]
17. Serum IgG antibody responses to pertussis toxin and filamentous hemagglutinin in nonvaccinated and vaccinated children and adults with pertussis.
Trollfors B; Taranger J; Lagergård T; Sundh V; Bryla DA; Schneerson R; Robbins JB
Clin Infect Dis; 1999 Mar; 28(3):552-9. PubMed ID: 10194077
[TBL] [Abstract][Full Text] [Related]
18. Seroprevalence of Bordetella pertussis antibodies in mothers and their newborn infants.
Gonik B; Puder KS; Gonik N; Kruger M
Infect Dis Obstet Gynecol; 2005 Jun; 13(2):59-61. PubMed ID: 16011994
[TBL] [Abstract][Full Text] [Related]
19. A nasal whole-cell pertussis vaccine induces specific systemic and cross-reactive mucosal antibody responses in human volunteers.
Berstad AKH; Holst J; Frøholm LO; Haugen IL; Wedege E; Oftung F; Haneberg B
J Med Microbiol; 2000 Feb; 49(2):157-163. PubMed ID: 10670566
[TBL] [Abstract][Full Text] [Related]
20. Pertussis Antibody Concentrations in Infants Born Prematurely to Mothers Vaccinated in Pregnancy.
Kent A; Ladhani SN; Andrews NJ; Matheson M; England A; Miller E; Heath PT;
Pediatrics; 2016 Jul; 138(1):. PubMed ID: 27255149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
